Therapeutic Advances in Psychopharmacology

Papers
(The H4-Index of Therapeutic Advances in Psychopharmacology is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
The role of Facebook groups in the management and raising of awareness of antidepressant withdrawal: is social media filling the void left by health services?45
What I have learnt from helping thousands of people taper off antidepressants and other psychotropic medications39
Clozapine discontinuation withdrawal symptoms in schizophrenia29
Current antipsychotic agent use and risk of venous thromboembolism and pulmonary embolism: a systematic review and meta-analysis of observational studies29
Repetitive transcranial magnetic stimulation for major depressive disorder: basic principles and future directions28
Transcranial magnetic stimulation for post-traumatic stress disorder25
Ketamine and esketamine in suicidal thoughts and behaviors: a systematic review24
Clinical pharmacist interventions in elderly patients with mental disorders in primary care focused on psychotropics: a retrospective pre–post observational study24
History repeating: guidelines to address common problems in psychedelic science24
Gut microbiome in schizophrenia and antipsychotic-induced metabolic alterations: a scoping review24
Systematic review and meta-analysis of randomized controlled trials of ketamine in the treatment of refractory anxiety spectrum disorders22
The role of lumateperone in the treatment of schizophrenia21
Clinical practice guideline recommendations on tapering and discontinuing antidepressants for depression: a systematic review20
Agomelatine for the treatment of generalized anxiety disorder: focus on its distinctive mechanism of action20
Cognitive effects of vortioxetine in older adults: a systematic review19
Successful use of tapering strips for hyperbolic reduction of antidepressant dose: a cohort study18
Efficacy and safety of lamotrigine in the treatment of bipolar disorder across the lifespan: a systematic review18
Clozapine augmentation with cariprazine for negative symptoms: a case series and literature review18
0.041846036911011